Literature DB >> 28237785

Multisite tumor sampling: a new tumor selection method to enhance intratumor heterogeneity detection.

José I López1, Jesús M Cortés2.   

Abstract

Intratumor heterogeneity (ITH) is increasingly being recognized as a highly complex process with high clinical impact that deserves special attention from practicing pathologists. The value of the ITH detection depends on the correctness of the pathologist's sampling. The goal of this review is 2-fold. On the one hand, we provide a basic scientific context for the practical pathologist's perspective. On the other hand, we encourage pathologists to adopt a more scientific and up-to-date approach to a key component of their daily work, namely, how to sample a tumor for reliable histological and molecular analysis. In particular, we review the consecutive steps of an efficient alternative to traditional approaches for detecting ITH: multisite tumor sampling. Notably, this type of sampling, based on a divide-and-conquer algorithm, is supported by scientific evidence showing its clinical applicability and practical advantages at no extra cost.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Carcinogenesis; Intratumor heterogeneity; Laboratory cost; Pathology; Targeted therapies; Tumor sampling

Mesh:

Substances:

Year:  2017        PMID: 28237785     DOI: 10.1016/j.humpath.2017.02.010

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  15 in total

1.  Multisite tumor sampling enhances the detection of intratumor heterogeneity at all different temporal stages of tumor evolution.

Authors:  Asier Erramuzpe; Jesús M Cortés; José I López
Journal:  Virchows Arch       Date:  2017-08-25       Impact factor: 4.064

2.  Sequential treatment of metastatic renal cancer in a complex evolving landscape.

Authors:  Javier C Angulo; Charles H Lawrie; José I López
Journal:  Ann Transl Med       Date:  2019-12

Review 3.  Understanding and overcoming tumor heterogeneity in metastatic breast cancer treatment.

Authors:  Nida Pasha; Nicholas C Turner
Journal:  Nat Cancer       Date:  2021-07-19

Review 4.  Clear Cell Renal Cell Carcinomas with Aggressive Behavior Display Low Intratumor Heterogeneity at the Histological Level.

Authors:  Claudia Manini; Estíbaliz López-Fernández; Charles H Lawrie; Annick Laruelle; Javier C Angulo; José I López
Journal:  Curr Urol Rep       Date:  2022-04-13       Impact factor: 3.092

Review 5.  A Critical Insight into the Clinical Translation of PD-1/PD-L1 Blockade Therapy in Clear Cell Renal Cell Carcinoma.

Authors:  Caroline E Nunes-Xavier; Javier C Angulo; Rafael Pulido; José I López
Journal:  Curr Urol Rep       Date:  2019-01-15       Impact factor: 3.092

Review 6.  Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.

Authors:  José I López; Javier C Angulo
Journal:  Curr Urol Rep       Date:  2018-01-27       Impact factor: 3.092

7.  New developments in existing WHO entities and evolving molecular concepts: The Genitourinary Pathology Society (GUPS) update on renal neoplasia.

Authors:  Kiril Trpkov; Ondrej Hes; Sean R Williamson; Anthony J Gill; Adebowale J Adeniran; Abbas Agaimy; Reza Alaghehbandan; Mahul B Amin; Pedram Argani; Ying-Bei Chen; Liang Cheng; Jonathan I Epstein; John C Cheville; Eva Comperat; Isabela Werneck da Cunha; Jennifer B Gordetsky; Sounak Gupta; Huiying He; Michelle S Hirsch; Peter A Humphrey; Payal Kapur; Fumiyoshi Kojima; Jose I Lopez; Fiona Maclean; Cristina Magi-Galluzzi; Jesse K McKenney; Rohit Mehra; Santosh Menon; George J Netto; Christopher G Przybycin; Priya Rao; Qiu Rao; Victor E Reuter; Rola M Saleeb; Rajal B Shah; Steven C Smith; Satish Tickoo; Maria S Tretiakova; Lawrence True; Virginie Verkarre; Sara E Wobker; Ming Zhou
Journal:  Mod Pathol       Date:  2021-03-04       Impact factor: 8.209

8.  Detection of Intratumor Heterogeneity in Modern Pathology: A Multisite Tumor Sampling Perspective.

Authors:  Jesús M Cortés; Giovanni de Petris; José I López
Journal:  Front Med (Lausanne)       Date:  2017-03-06

Review 9.  The Changing Therapeutic Landscape of Metastatic Renal Cancer.

Authors:  Javier C Angulo; Oleg Shapiro
Journal:  Cancers (Basel)       Date:  2019-08-22       Impact factor: 6.639

Review 10.  The Impact of Tumor Eco-Evolution in Renal Cell Carcinoma Sampling.

Authors:  Estíbaliz López-Fernández; José I López
Journal:  Cancers (Basel)       Date:  2018-12-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.